Effect of TNF-Alpha on Caveolin-1 Expression and Insulin Signaling during Adipocyte Differentiation and in Mature Adipocytes

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1499-1516

  Palacios Ortega, Sara ^a   Varela Guruceaga, Maider ^a   Algarabel, Miriam ^a   Milagro, Fermín Ignacio ^a,b   Martínez, J Alfredo ^a,b   De Miguel, Carlos ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

3T3 L1; Adipogenesis; DNA methylation; Inflammation; Insulin receptor; Insulin stimulated glucose uptake

Indexed keywords

CAVEOLIN 1; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; LIPID; PROTEIN KINASE B BETA; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE;

3T3 CELL LINE; ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; INSULIN SIGNALING; LIPID STORAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL SURVIVAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; INSULIN RESISTANCE; LIPID METABOLISM; METABOLISM; PHOSPHORYLATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOKINES; ANIMALS; CAVEOLIN 1; CELL SURVIVAL; DNA METHYLATION; GENE EXPRESSION REGULATION; GLUCOSE; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MICE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84936971908     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430314     Document Type: Article

References (50)

1. Matsui Y, Tomaru U, Miyoshi A, Ito T, Fukaya S, Miyoshi H, Atsumi T, Ishizu A: Overexpression of TNF converting enzyme promotes adipose tissue inflammation and fibrosis induced by high fat diet. Exp Mol Pathol 2014;12;97:354-358.
2. Hube B, Lee H: Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1999;29:672-678.
3. Serrano-Marco L, Chacón MR, Maymó-Masip E, Barroso E, Salvadó L, Wabitsch M, Garrido-Sánchez L, Tinahones FJ, Palomer X, Vendrell J, Vazquez-Carrera M: TNF- inhibits PPAR/ activity and SIRT1 expression through NF-B in human adipocytes. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 2012 9;1821:1177-1185.
4. Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF: Tumor Necrosis Factor- Suppresses Adipocyte-Specific Genes and Activates Expression of Preadipocyte Genes in 3T3-L1 Adipocytes: Nuclear Factor-B Activation by TNF- Is Obligatory. Diabetes 2002;01:1319-1336.
5. Song D, Chen Y, Li Z, Guan Y, Zou D, Miao C: Protein tyrosine phosphatase 1B inhibits adipocyte differentiation and mediates TNF action in obesity. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids 2013;8;1831:1368-1376.
6. Kudo M, Sugawara A, Uruno A, Takeuchi K, Ito S: Transcription suppression of peroxisome proliferatoractivated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation. Endocrinology 2004;145:4948-4956.
7. Gong M, Liu C, Zhang L, Zhang H, Pan J: Loss of the TNFalpha function inhibits Wnt/beta-catenin signaling, exacerbates obesity development in adolescent spontaneous obese mice. Mol Cell Biochem 2014;391:59-66.
8. Hammarstedt A, Isakson P, Gustafson B, Smith U: Wnt-signaling is maintained and adipogenesis inhibited by TNFalpha but not MCP-1 and resistin. Biochem Biophys Res Commun 2007;8;357:700-706.
9. Jin D, Sun J, Huang J, He Y, Yu A, Yu X, Yang Z: TNF-alpha reduces g0s2 expression and stimulates lipolysis through PPAR-gamma inhibition in 3T3-L1 adipocytes. Cytokine 2014;69:196-205.
10. Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF: Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. Cell Physiol Biochem 2014;34:1983-1997.
11. Oh DJ, Kim HR, Lee MK, Woo YS: Profile of human beta-defensins 1,2 and proinflammatory cytokines (TNFalpha, IL-6) in patients with chronic kidney disease. Kidney Blood Press Res 2013;37:602-610.
12. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha-and obesity-induced insulin resistance. Science 1996;2;271:665-668.
13. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 2006;116:1793-1801.
14. Sekimoto J, Kabayama K, Gohara K, Inokuchi J: Dissociation of the insulin receptor from caveolae during TNFalpha-induced insulin resistance and its recovery by D-PDMP. FEBS Lett 2012 20;586:191-195.
15. Kabayama K, Sato T, Saito K, Loberto N, Prinetti A, Sonnino S, Kinjo M, Igarashi Y, Inokuchi J: Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proc Natl Acad Sci U S A 2007;21;104:13678-13683.
16. Nystrom FH, Chen H, Cong LN, Li Y, Quon MJ: Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol 1999;13:2013-2024.
17. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG: Caveolin, a protein component of caveolae membrane coats. Cell 1992;21;68:673-682.
18. Parton RG, Simons K: The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007;8:185-194.
19. Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP: Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. Am J Physiol Cell Physiol 2003;285:C222-35.
20. Gonzalez-Munoz E, Lopez-Iglesias C, Calvo M, Palacin M, Zorzano A, Camps M: Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3T3-L1 adipocytes. Endocrinology 2009;15:3493-3502.
21. Yuan T, Hong S, Yao Y, Liao K: Glut-4 is translocated to both caveolae and non-caveolar lipid rafts, but is partially internalized through caveolae in insulin-stimulated adipocytes. Cell Res 2007;17:772-782.
22. Palacios-Ortega S, Varela-Guruceaga M, Milagro FI, Martinez JA, de Miguel C: Expression of Caveolin 1 is enhanced by DNA demethylation during adipocyte differentiation. status of insulin signaling. PLoS One 2014;21;9:e95100.
23. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE: Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001;9:414-417.
24. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G: Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001;280:E745-51.
25. Bjorbaek C: Central leptin receptor action and resistance in obesity. J Investig Med 2009;57:789-794.
26. Myers MG,Jr, Leibel RL, Seeley RJ, Schwartz MW: Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 2010;21:643-651.
27. Landgraf MA, Silva RC, Correa-Costa M, Hiyane MI, Carvalho MH, Landgraf RG, Camara NO: Leptin downregulates LPS-induced lung injury: role of corticosterone and insulin. Cell Physiol Biochem 2014;33:835-846.
28. Franck N, Stenkula KG, Ost A, Lindström T, Stralfors P, Nystrom FH: Insulin-induced GLUT4 translocation to the plasma membrane is blunted in large compared with small primary fat cells isolated from the same individual. Diabetologia 2007;50:1716-1722.
29. Yang J, Eliasson B, Smith U, Cushman S, Sherman A: The size of large adipose cells is a predictor of insulin resistance in first-degree relatives of type 2 diabetic patients. Obesity 2012;20:932-938.
30. Daya S, Loughlin AJ, Macqueen HA: Culture and differentiation of preadipocytes in two-dimensional and three-dimensional in vitro systems. Differentiation 2007;75:360-370.
31. Castro-Munozledo F, Beltran-Langarica A, Kuri-Harcuch W: Commitment of 3T3-F442A cells to adipocyte differentiation takes place during the first 24-36 h after adipogenic stimulation: TNF-alpha inhibits commitment. Exp Cell Res 2003;1;284:163-172.
32. Stephens JM, Butts MD, Pekala PH: Regulation of transcription factor mRNA accumulation during 3T3-L1 preadipocyte differentiation by tumour necrosis factor-alpha. J Mol Endocrinol 1992;9:61-72.
33. Wei YT, Xia DS, Yang WK, Wang XG, Chen XZ, Dong NG: Secretion of adipocytes and macrophages under conditions of inflammation and/or insulin resistance and effect of adipocytes on preadipocytes under these conditions. Biochemistry (Mosc) 2014 79:663-671.
34. Stephens JM, Morrison RF, Pilch PF: The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 1996;271:10441-10444.
35. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF: Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 1994;127:1233-1243.
36. Stephens JM, Lee J, Pilch PF: Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 1997;10;272:971-976.
37. Stephens JM, Pekala PH: Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 1991;15;266:21839-21845.
38. Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB: Cell typespecific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/ Akt signaling to NF-kappa B activation. J Biol Chem 2004 16;279:1615-1620.
39. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85.
40. Yang X, Zhang X, Heckmann BL, Lu X, Liu J: Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-alpha (TNF-alpha)-induced lipolysis in adipocytes. J Biol Chem 2011;286:40477-40485.
41. Yamaguchi M, Murakami T, Tomimatsu T, Nishio Y, Mitsuda N, Kanzaki T, Kurachi H, Shima K, Aono T, Murata Y: Autocrine inhibition of leptin production by tumor necrosis factor-alpha (TNF-alpha) through TNF-alpha type-I receptor in vitro. Biochem Biophys Res Commun 1998;244:30-34.
42. Medina EA, Stanhope KL, Mizuno TM, Mobbs CV, Gregoire F, Hubbard NE, Erickson KL, Havel PJ: Effects of tumor necrosis factor alpha on leptin secretion and gene expression: relationship to changes of glucose metabolism in isolated rat adipocytes. Int J Obes Relat Metab Disord 1999;23:896-903.
43. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S,Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem Biophys Res Commun 2012;425:560-564.
44. Matsunaga T, Shoji A, Gu N, Joo E, Li S, Adachi T, Yamazaki H, Yasuda K, Kondoh T, Tsuda K: gamma-Tocotrienol attenuates TNF-alpha-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol Med Rep 2012;5:905-909.
45. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K: Adiponectin and adiponectin receptors in obesity-linked insulin resistance. Novartis Found Symp 2007;286:164-76; discussion 176-82, 200-3.
46. Kabayama K, Sato T, Kitamura F, Uemura S, Kang BW, Igarashi Y, Inokuchi J: TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 2005;15:21-29.
47. Lee H, Xie L, Luo Y, Lee SY, Lawrence DS, Wang XB, Sotgia F, Lisanti MP, Zhang ZY: Identification of phosphocaveolin-1 as a novel protein tyrosine phosphatase 1B substrate. Biochemistry 2006;10;45:234-240.
48. Stralfors P: Caveolins and caveolae, roles in insulin signalling and diabetes. Adv Exp Med Biol 2012;729:111-126.
49. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG,Jr, Ishikawa Y: Caveolin is an activator of insulin receptor signaling. J Biol Chem 1998;273:26962-26968.
50. Kimura A, Mora S, Shigematsu S, Pessin JE, Saltiel AR: The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. J Biol Chem 2002;277:30153-30158.